Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ocular Therapeutix announces topline results of phase 3 trial of dextenza for treatment of ocular itching associated with allergic conjunctivitis
Ocular Therapeutix announces topline results of phase 3 trial of dextenza for treatment of ocular itching associated with allergic conjunctivitis. (Credit: fernando zhiminaicela from Pixabay)